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Detection of physiological deterioration
by the SNAP40 wearable device compared
to standard monitoring devices in the
emergency department: the SNAP40-ED
study
Matthew J. Reed1,2,5* , Megan McGrath1, Polly L. Black1, Steff Lewis4, Christopher McCann3, Stewart Whiting3,
Rachel O’Brien1, Alison Grant1, Beth Harrison1, Laura Skyrme1 and Miranda Odam1
Abstract
Background: In recent years, there has been increasing focus on the earlier detection of deterioration in the clinical
condition of hospital patients with the aim of instigating earlier treatment to reverse this deterioration and prevent
adverse outcomes. This is especially important in the ED, a dynamic environment with large volumes of undifferentiated
patients, which carries inherent patient risk. SNAP40 is an innovative medical-grade device that can be worn on the upper
arm that continuously monitors patients’ vital signs including relative changes in systolic blood pressure, respiratory rate,
heart rate, movement, blood oxygen saturation and temperature. It uses automated risk analysis to potentially allow
clinical staff to easily and quickly identify high-risk patients. The aim of this study is to investigate whether the SNAP40
device is able to identify deterioration in the vital sign physiology of an ED patient earlier than current standard
monitoring and observation charting techniques.
Methods/design: Single centre, teaching hospital ED open label, prospective, observational cohort study recruiting
250 high acuity participants aged 16 years or over presenting to the ED. Participants will be approached and enrolled
in the ED and after consent will have the SNAP40 wearable monitoring device attached which will be used alongside
standard care monitoring. Participants will be observed throughout their time in the ED. Any SNAP40 device alarm,
standard monitoring alarms or standard practice vital sign observations indicating a deterioration in a patient’s vital
sign physiology (defined as an increase in NEWS score) will be recorded. Primary outcome is time to detection of
deterioration. Secondary outcomes include staff time spent performing observations and responding to standard
monitoring alarms, clinical escalation of care when deterioration is detected and participants and staff rating of
experience of both SNAP40 and current monitoring.
(Continued on next page)
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Discussion: The SNAP40-ED study aims to recruit 250 patients. It will be the first study to compare the ability of a
novel ambulatory monitoring device to detect deterioration compared to standard care in the ED. It may allow the
earlier detection of deterioration in the clinical condition of ED patients and therefore earlier treatment to reverse this
deterioration and prevent adverse outcomes.
Trial registration: NCT03179267 ClinicalTrials.gov. Registered on June 17, 2017
Keywords: Ambulatory monitoring, Monitoring, physiological, Patient monitoring, Clinical deterioration
Background
In the last decade, there has been increasing focus on
the earlier detection of deterioration in the clinical con-
dition of hospital patients with the aim of instigating
earlier treatment to reverse this deterioration and pre-
vent adverse outcomes. In studies of cardiac arrest, it
was recognised that it was the final step in a series of
events [1] that often went overlooked and once cardiac
arrest occurred, prognosis was vastly reduced [2]. The
NCEPOD 2012 report on in hospital cardiac arrest [3]
showed 73% of patients had at least one marker of in-
stability prior to cardiac arrest. In 62%, this was present
6 h prior to cardiac arrest, and in 47%, this was present
12 h before. This deterioration had not been recognised
in 36% of cases, and in 38% of cases, the cardiac arrest
could have been prevented altogether. These and many
other studies led to an agreement that earlier recogni-
tion of physiological derangement may allow the possi-
bility of improving patient outcomes. Focus turned
firstly to techniques to improve the detection of physio-
logical derangement, and secondly to strategies to allow
these physiological derangements to be addressed once
detected, for example with medical emergency teams
(MET) [4].
The recognition of physiological derangement however
is still problematic. The 2013 UK Parliamentary and
Health Service Ombudsman report ‘Time to act—Severe
sepsis: rapid diagnosis and treatment saves lives’
highlighted that the lack of early recognition and proper
monitoring led to worse patient outcomes and increased
costs [5]. Practice in the emergency department (ED) is
seemingly no better with the 2011–2012 Royal College
of Emergency Medicine audit report finding that the
monitoring of vital signs in patients who went on to de-
velop severe sepsis or septic shock was below standard
and led to later recognition and poorer outcomes [6].
The availability of senior clinicians trained in man-
aging the acute deteriorating patient is not as problem-
atic in the ED as on hospital wards where solutions such
as MET teams are required. The ED however is a dy-
namic environment with large volumes of undifferenti-
ated patients, which carries inherent patient risk. EDs
across the UK also now have increase demand, greater
financial pressures, critical staffing issues and patient
flow issues with exit block [7]. Recognition of deteriorat-
ing patients within the ED is a significant patient safety
concern, and techniques to improve the detection of
physiological derangement have included Early Warning
Scores (EWS) such as National Early Warning Score
(NEWS) [8]. The Royal College of Emergency Medicine
and Royal College of Physicians support the use of the
NEWS within EDs to improve recognition of deteriorat-
ing patients and escalation of physiological unstable pa-
tients to senior doctors [9, 10]. NEWS works on a
scoring system (Table 1) that, along with clinical judge-
ment, is used to inform a structured response.
Despite the introduction of EWS, early recognition of
physiological instability remains an issue [5, 11–13].
Although it is clear that healthcare staff do ultimately
recognise patients that are critically ill, crucial time is
being lost [14] leading to increased patient length of
stay, increased deaths and increased admissions to ICU
[15]. The likely problem is that EWS rely on staff manu-
ally taking and documenting observations at set intervals
which is problematic in a busy ED.
The recent ubiquitous rise in smart phones and inter-
net access has led to a surge in applications which inter-
connect everyday objects with the internet (https://
www.wired.com/2013/05/internet-of-things-2). Devices
such as fitness devices and smart watches are common-
place with one in six consumers in the USA currently using
wearable technology (https://www.forbes.com/sites/ber-
nardmarr/2016/03/18/15-mind-boggling-facts-about-wear-
ables-in-2016/#1b6706b27323). Wearable medical-grade
devices (e.g. continuous blood glucose monitoring in dia-
betes, electrocardiogram (ECG) recording and falls preven-
tion in the elderly have followed, and NHS England’s Five
Year Forward document highlights the requirement for ex-
ploitation of the information revolution to accelerate
health innovation [16].
SNAP40 is an innovative medical-grade device that can
be worn on the upper arm. The device continuously moni-
tors patients’ vital signs including relative changes in sys-
tolic blood pressure, respiratory rate, heart rate, movement,
blood oxygen saturation and temperature. It uses auto-
mated risk analysis to potentially allow clinical staff to easily
and quickly identify high-risk patients. It has the potential
to reduce the time taken for staff to detect deterioration in
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patient physiology using NEWS score-based changes as
well as other specific contributing physiological markers.
The scoring system is the same as with NEWS
(Table 1) except for two parameters, blood pressure
and movement. A score of ‘1’ is given if the blood
pressure increases or decreases by 15% of the pa-
tient’s initial reading. Movement is recorded as either
‘normal’ or ‘reduced’. If movement is reduced, then a
score of ‘1’ is given. As well as the potential of the
SNAP40 device to improve patient safety, it may po-
tentially increase ED efficiency, improve and increase
use of resources and improve patient flow.
Currently, the only option for continuous monitoring or
regular observations in the ED is to connect the patient to
a standard monitor. Whilst these monitors can be portable,
they are not lightweight enough to allow the patient to be
ambulatory and therefore require the patient to have a bed
and a bed space or cubicle. This leads to lack of space
within the ED, less cubicles (which allow privacy) free for
performing history taking, examination and procedures, dif-
ficulty accessing patients and difficulty transporting them
to areas where specialist tests can be performed (i.e. radi-
ology and ECG). SNAP40 may remove the need for pa-
tients to be confined to beds and bed spaces (unless
clinically required) freeing up space within the ED and
allowing the ED care processes to occur much more freely,
increasing efficiency and speed of patient processing. This
may lead to improved patient ED and hospital experience.
The SNAP40 device may also potentially free up re-
sources (e.g. reducing time clinical staff record observa-
tions), which can be used to improve patient care and
experience in the ED (e.g. timelier analgesia and treat-
ments, more time for communication and traditional
nursing and personal care).
There are some other similar medical devices on the
market (i.e. www.biovotion.com, www.sensium-health
care.com, www.vitalconnect.com, www.caretakermedi
cal.net) using wristbands, patches or finger cuff technol-
ogy, and whilst these devices may be suitable, none cur-
rently are being used in ED clinical practice. The
SNAP40 device was chosen by the SBRI for study in the
ED environment and is therefore the chosen device for
our study.
This study will examine the SNAP40 device by com-
paring its performance to detect physiological deterior-
ation against standard observations taken by clinical
staff (nurses, doctors and clinical support workers)
within the ED. The study will assess whether the device
is able to detect physiological derangement sooner than
standard monitoring devices.
Study aims
Primary aim
The primary aim of the study is to investigate whether
the SNAP40 device is able to identify deterioration in
the vital sign physiology of an ED patient earlier than
current standard monitoring and observation charting
techniques.
Secondary aims
1. To determine whether the SNAP40 device can
potentially reduce the time ED staff spend
performing and charting observations and
responding to standard monitoring alarms
2. To assess how often a change in the vital sign
physiology of an ED patient leads to a clinical
escalation or de-escalation of care
3. To study ED patient experience rating of both
SNAP40 and current monitoring techniques and
patient confidence with future SNAP40 device
use alone
4. To study ED staff experience rating of both
SNAP40 and current monitoring techniques and
ED staff confidence with future SNAP40 device
use alone
Methods
Design
This is a single centre, teaching hospital ED open label,
prospective, observational cohort study.
Table 1 National Early Warning Score (NEWS) [10]
Physiological parameters 3 2 1 0 1 2 3
Respiration rate ≤ 8 9–11 12–20 21–24 ≥ 25
Oxygen saturations ≤ 91 92–93 94–95 ≥ 96
Any supplemental Oxygen Yes No
Temperature ≤ 35.0 35.1–36.0 36.1–38.0 38.1–39.0 ≥ 39.1
Systolic BP ≤ 90 91–100 101–110 111–219 ≥ 220
Heart rate ≤ 40 41–50 51–90 91–110 111–130 ≥ 131
Level of consciousness A V, P or U
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Setting
The setting is the ED of the Royal Infirmary of Edin-
burgh (RIE). The RIE sees approximately 120,000 pa-
tients per year of whom approximately half are deemed
to be majors level acuity.
Primary endpoint
Time to detection of deterioration in an ED patient’s
vital sign physiology is defined as an increase in NEWS
score. This would include a deterioration in blood pres-
sure, pulse/heart rate, respiratory rate, skin temperature
(SNAP40)/core temperature (standard), oxygen satur-
ation reading or movement (SNAP40)/Glasgow Coma
Scale (GCS) (standard).
Secondary endpoints
1. Time ED staff spend performing a charting
observations and responding to standard
monitoring alarms
2. Percentage clinical escalation of care when
deterioration detected
3. Participants rating of experience of both SNAP40
and current monitoring
4. Research nurse rating of experience of both
SNAP40 and current monitoring
We have not performed power calculations for our
secondary outcomes that are purely descriptive and
for qualitative purposes. We aim to recruit 250
participants into the study. We will aim to recruit at
least 50 participants who are triaged to a
non-monitored area and at least 50 participants who
are triaged to continuous monitoring. Other re-
cruited participants will have variable levels of obser-
vation charting as determined by the treating clinical
team. After surveying a group of ED and critical
care physicians, we selected an increase in NEWS
score of + 1 as being a clinically significant endpoint.
Population
Two hundred fifty participants aged 16 years or over
presenting to the ED of the RIE who are triaged to ma-
jors (high dependency or immediate care) or who are
stepped down from resuscitation room care to high de-
pendency or immediate care shall be recruited into the
study. Recruitment will last around 4 months.
Inclusion criteria
1. Participant aged 16 years or over
2. Participant triaged to majors (high dependency or
immediate care)
3. Participants who are stepped down from
resuscitation room care to high dependency or
immediate care
Exclusion criteria
1. Participants under 16 years of age
2. Previous participation in the study
3. Participant in custody
4. Participants deemed high risk for absconding by
clinical staff
5. Participants unable to communicate in English
6. Participants who are triaged to immediate
resuscitation. These participants may be considered
for inclusion once immediate assessment and
treatment have been initiated and they are stepped
down to high dependency (HD)/immediate care
(IC) areas
7. Patients with implantable defibrillators, pacemakers
or neurostimulators will be excluded
8. Patients who cannot have blood pressure measured
in both arms, e.g. patients with renal fistula and a
peripherally inserted central catheter (PICC) line, or
who have had a lymph node clearance
n.b. Scotland A Research Ethics Committee approved
inclusion of participants lacking capacity.
Patient selection and enrolment
Participants will be assessed at the RIE ED majors tri-
age area and those appropriate for the majors area of
the ED (including both HD and IC areas) deemed by
the treating clinical team will be eligible for inclusion
in the study. Participants who are stepped down from
resuscitation room care will also be eligible for inclu-
sion in the study.
Potential participants or their relative, guardian or wel-
fare attorney (if lacking capacity) will be approached by
a member of the study research team (if a member of
the usual care team) or direct care clinician if suitably
trained. The potential participants or their relative will
receive a copy of the participant information sheet. If
the participant has capacity and is agreeable to partici-
pate in the study, then informed consent will be taken
from the participant. Where a potential participant lacks
capacity, informed written consent will be gained from a
relative, guardian or welfare attorney.
The study researcher will apply the SNAP40 device and
alert the clinical staff in the HD/IC area that the partici-
pant has been included in the study. The study team will
explain to the clinical team that the study is assessing the
performance of the SNAP40 device. If a participant is
moved to the HD or IC area of the ED, then a study re-
searcher will monitor the cubicle that they are assigned to.
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The study team will ensure that study participants are
transferred to cubicles whose monitor’s alarms have been
set to reflect the NEWS abnormal boundaries for blood
pressure, pulse/heart rate, respiratory rate and oxygen sat-
uration. All monitors being used in this study will be
checked and reset to reflect NEWS parameters prior to
the study starting. It is anticipated that some of the IC
participants will be ambulatory within the ED. If such a
participant is then deemed to require standard monitor-
ing, the clinical staff will inform the study team and a
study researcher will monitor the cubicle. Allowing for de-
partmental workload, the research team will attempt to
ensure that any cubicles with a study participant are
within vision of the study researcher without changing the
participant’s clinical priority categorisation.
Screening for eligibility
Potentially eligible patients will be identified by medical and
nursing staff in the ED and also by the Emergency Medi-
cine Research Group of Edinburgh (EMERGE) researchers
(part of the patient’s direct care team) screening in accord-
ance with EMERGE Research Governance: Data protection
and Confidentiality SOP current version. Eligibility will be
confirmed by the study researcher delegated to the study.
Non-recruited but potentially eligible patients aged
16 years or over, triaged to high dependency (HD)/
immediate care (IC) areas will be identified by a search
of all ED attendances at the end of the study to estimate
the proportion of ED attendances who have participated
in the study.
Treatment allocation
Participants will firstly be allocated a participant study
number. Basic demographic data and the participant’s
baseline observations will then be collected from each
participant at enrolment and recorded in the case re-
port form (CRF). The study researchers will then allo-
cate the participant a SNAP40 device. Each device
has a unique ‘identifier’ that will be recorded on the
CRF and also on a separate recruitment log. This will
allow the clinical vital sign and clinical alert data
from each participant to be collected and recorded on
the CRF along with the alerts from the SNAP40 de-
vice for the same participant. If a new device (e.g. be-
cause of a depleted battery) replaces a SNAP40 device
already worn by a participant, the unique ID of the
new device along with the reason for replacement
and time it is assigned will be recorded on the CRF.
No patient identifiable information will be entered
into the SNAP40 system.
Study interventions
The SNAP40 device will be placed onto the participant’s
arm. The opposite arm will therefore be available for any
standard observation recordings in the department at
the discretion of the clinical team. The information from
the SNAP40 device will be observed by the research
team only and will not be used as an alternative to
standard care or clinical observations of the participant
whilst they are in the ED. The participant will continue
to have their vital signs monitored by the clinical team
as per standard practice.
The SNAP40 wearable device will continuously monitor
participants throughout their stay and transmit three key
signals: photoplethysmograph (PPG) waveform using
green, red and infrared light; skin temperature and move-
ment. Anonymised SNAP40 monitoring data will be
transmitted continuously by the SNAP40 device via a se-
cure Wi-Fi connection to a SNAP40 server located in the
ED. The anonymised SNAP40 monitoring data will be
transmitted along with the date and time of the observa-
tion and the unique device ID. This will allow the anon-
ymised monitoring data to be associated with the
participant study number. The anonymised SNAP40 mon-
itoring data will be securely stored with access restricted
to the study staff and authorised SNAP40 personnel. This
anonymised SNAP40 monitoring data may be used by
SNAP40 in future for product development.
Signal processing algorithms developed by SNAP40 will
calculate heart rate, respiratory rate, blood pressure and
oxygen saturations from the PPG every 2 s. The SNAP40
device measures change in blood pressure. The SNAP40
device will alert the study researcher in real time via a
smartphone or tablet application should the participant’s
vital sign physiology change from one NEWS category to
a higher one in any of pulse/heart rate, respiratory rate,
skin temperature or oxygen saturation reading. Physio-
logical changes relating to blood pressure and movement
do not relate to the NEWS score. If blood pressure in-
creases or decreases by 15% of the participant’s baseline,
the score increases (or decreases) by ‘1’. If movement is
monitored by the device as ‘reduced’, the score is increased
by ‘1’. The study researcher will record any deterioration
alerts on the CRF. The time of each alarm, reason for each
alarm (i.e. parameter for which the alarm was triggered)
and new individual component NEWS score will be re-
corded each time the SNAP40 device sends an alarm to
the study team.
The participant will be monitored by the device for a
maximum of 4 h during their stay in the ED. The device
will be removed prior to the participant being discharged
from the ED or admitted to the hospital. Participants will
be asked to complete a questionnaire to rate their experi-
ence of the SNAP40 device and current monitoring.
As well as recording the SNAP40 alarms, the research
team will also observe and record standard practice cur-
rently being utilised when observing and monitoring the
participant’s vital signs. What the researcher records will
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differ slightly between participants triaged to high depend-
ency (HD) and immediate care (IC). At the end of the
study, research nurses who have worked with the SNAP40
device will be asked to complete a questionnaire rating
their experience of both SNAP40 and current monitoring.
Participants who are triaged to HD
The frequency of vital sign recordings will be set at the
discretion of the clinical staff and according to the par-
ticipant’s clinical priority categorisation. Each time the
standard alarms on the Mindray monitor sound, the re-
search team will record the reason for alarm (e.g. param-
eter for which the alarm was triggered) in any of blood
pressure, pulse/heart rate, respiratory rate or oxygen sat-
uration reading and new NEWS parameter score. The
study researcher will record any such alerts on the CRF.
The time taken to respond and the response to these
alarms (e.g. silencing alarm, escalation in care) will also
be recorded by the research team. Escalation in care will
include ED medical or senior nursing staff review, other
speciality review, critical care review and movement to
the resuscitation bay or to an area of increased priority.
Raw data from the Mindray monitors will not be ex-
tracted and stored.
Total time spent recording all observations will be
noted for at least 25 patients in the study. To do this,
the research team will, where possible, time how long
clinical staff spend recording each observation on the
NEWS chart. If the researcher is unable to time an ob-
servation being completed by a staff member, this will
be indicated on the CRF. The total number of observa-
tions recorded, along with the total number timed and
not timed will also be recorded on the CRF.
The NEWS chart recordings noted on the participant’s ED
shock chart (i.e. blood pressure, pulse/heart rate, respiratory
rate, oxygen saturation reading, core temperature using a
tympanic temperature probe and neurological status assessed
by GCS) will also be reviewed, and any deterioration in
NEWS score will be recorded in the CRF. The time and par-
ameter for which the NEWS score changed will be recorded.
A photocopy of the participant’s ED shock chart will be taken
prior to them leaving the ED in order to ensure all data is
collected and allow it to be checked later on if necessary.
This chart will be anonymised with the participant study
number and kept with the participant’s study paperwork.
Participants who are triaged to IC
The frequency of vital sign recordings will be set at the
discretion of the clinical staff and according to the par-
ticipant’s clinical priority categorisation. Each time the
participant has their observations taken by a clinical staff
member, the research team will record the time taken,
and again where possible, total time taken to complete
the observation. As above, if the researcher is unable to
time an observation being completed by a staff member,
this will be noted on the CRF. The total number of ob-
servations recorded, along with the total number timed
and not timed, will be recorded on the CRF.
Clinical staff response (i.e. nothing done, escalation
in care) to a deterioration in NEWS score will also
be recorded in the CRF. Escalation in care includes
ED medical or senior nursing staff review, other spe-
ciality review, critical care review and movement to
the resuscitation bay or to an area of increased pri-
ority. It is hoped that the researcher will observe, in
real time, the response to any deterioration in
NEWS and record this on the CRF. However if this
is missed, the researcher will retrospectively ask the
member of staff taking care of the patient what was
done, if anything, about it. A photocopy of the par-
ticipant’s ED shock chart will be taken prior to them
leaving the ED in order to allow this data to ensure
all data is collected and allow it to be checked later
on if necessary. This chart will be anonymised with
the participant study number and kept with the par-
ticipant’s study paperwork.
The participant’s CHI number, episode number, par-
ticipant study number and their allocated SNAP40 ‘iden-
tifier’ number will be recorded on a separate database
held on a secure password protected drive. This data-
base will only be able to be accessed by NHS study staff
and will not leave the NHS. This will also ensure that no
participant identifiable information is contained with the
CRF or electronic CRF.
The SNAP40 device is being used alongside usual care
equipment and not instead of it. In this study, the study
team will not intervene to inform clinical staff should
deterioration in a patient’s vital sign physiology be de-
tected by the SNAP40 device except for the extreme fol-
lowing examples in which case they will intervene as
appropriate to the situation:
 Cardiorespiratory arrest
 Blood pressure reading showing increase or decrease
 Pulse/heart rate < 40 or > 200
 Respiratory rate < 5
 Oxygen saturation < 80%
If a standard alarm is not answered by the clinical
team and on investigating it is for one of the above rea-
sons, then again the research team will intervene as ap-
propriate to the situation.
The CRF will contain several questions relating to
participant and staff satisfaction of both SNAP40 and
current monitoring, and participant and staff confi-
dence in the detection of abnormal vital signs in the
ED which will be posed to participants and clinical
staff involved in the study.
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Trial assessment schedule
Participant follow-up
Data collection
Participants will have information collected on their
CRF during index hospitalisation transferred to a
specially designed electronic case report form
(eCRF) database. No patient identifiable information
will be entered onto this specially designed eCRF
database.
Statistics and sample size calculation
A small pilot study in the RIE ED demonstrated that
20% of patients experienced deterioration in NEWS
score during their ED stay. We aim to recruit 250
patients. Assuming that 20% of them deteriorate, we
will have 90% power to detect an effect size of 0.468
and 80% power to detect an effect size of 0.404
(paired t test, two sided p = 0.05). Appropriate statis-
tical analysis will be performed. A statistical analysis
plan will be prepared by the study statistician.
Study conduct and protocol amendments
Any changes in research activity, except those necessary
to remove an apparent, immediate hazard to the partici-
pant in the case of an urgent safety measure, must be
reviewed and approved by the chief investigator.
Amendments to the protocol must be submitted in writ-
ing to the appropriate REC and local R&D for approval
prior to participants being enrolled into an amended
protocol. A data monitoring committee has not been
established.
Protocol violations and deviations
Protocol deviations will be recorded in a protocol devi-
ation log, and logs will be submitted to the sponsors every
3 months. Each protocol violation will be reported to the
sponsor within 24 h of becoming aware of the violation.
The investigators are responsible for the detection
and documentation of adverse events. Participants or
their relatives will be instructed to contact the study
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team at any time after consenting to join the trial if
any symptoms develop. All adverse events (AE) that
occur after joining the trial must be reported in detail
in the case report form (CRF) or AE form. In the
case of an AE, the investigators should initiate the
appropriate treatment according to their medical
judgement. The only AEs and SAEs recorded will be
those directly related to the use and application of
the SNAP40 device. The sponsor has a legal responsi-
bility to notify the relevant Research Ethics Commit-
tee that approved the trial.
The study will be coordinated by a Project Manage-
ment Group consisting of the CI, co-investigators, statis-
tician and research team. A delegation log will be
prepared detailing the responsibilities of each member of
staff working on the study. Study monitoring and audit
will be the responsibility of the sponsor.
Confidentiality
All evaluation forms, reports and other records will
be identified in a manner designed to maintain par-
ticipant confidentiality. All paper records including
CRFs will be kept in a secure storage area, in this
case in a locked filing cabinet in the EMERGE office
which has limited access.
The participant’s CHI number, episode number, par-
ticipant study number and their allocated SNAP40 ‘iden-
tifier’ number will be recorded on a separate electronic
database held on a secure password protected drive.
This database will only be able to be accessed by NHS
study staff and will not leave the NHS. This will also en-
sure that no participant identifiable information is con-
tained with the CRF or electronic CRF.
The anonymised SNAP40 monitoring data will be se-
curely stored with access restricted to the study staff and
authorised SNAP40 personnel. This anonymised SNAP40
monitoring data may be used by SNAP40 in future for
product development.
Anonymised information collected on the CRF will be
entered onto a secure database. Members of the study
team including those from the University of Edinburgh’s
Clinical Trials Unit will view this. This anonymised in-
formation may be made available to other researchers in
future. No patient identifiable information will leave
NHS Lothian in any form whatsoever.
The CI and study site staff involved with this study
may not disclose or use for any purpose other than
performance of the study, any data, record or other
unpublished, confidential information disclosed to those
individuals for the purpose of the study.
Reporting, publication and notification of results
Ownership of the data arising from this study resides
with SNAP40. On completion of the study, the study
data will be analysed and a clinical study report will
be prepared. The clinical study report may be used
for publication and presentation at scientific meetings.
The patient information sheet and consent form was
reviewed by the EMERGE patient and public involve-
ment group.
Discussion
The SNAP40-ED study aims to recruit 250 patients. It will
be the first study to compare the ability of a novel ambula-
tory monitoring device to detect deterioration compared
to standard care in the ED. It may allow the earlier detec-
tion of deterioration in the clinical condition of ED
patients and therefore earlier treatment to reverse this
deterioration and potentially prevent adverse outcomes.
Trial status
The trial opened to recruitment on 25 September 2017
and is anticipated to run until February 2018 with trial
completion by the end of August 2018. As of November
2017, 50% of the study population was recruited. This is
protocol version number 3.0, dated 12/12/2017.
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